Mechanism of hypolipidemic effect of crocin in rats: Crocin inhibits pancreatic lipase

被引:199
作者
Sheng, Liang [1 ]
Qian, Zhiyu [1 ]
Zheng, Shuguo [1 ]
Xi, Liang [1 ]
机构
[1] China Pharmaceut Univ, Nanjing 210009, Peoples R China
关键词
hypertriglyceridemia; hypercholesterolemia; crocin; pancreatic lipase; (rat);
D O I
10.1016/j.ejphar.2006.05.038
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The hypolipidemic mechanism of crocin, an active ingredient in Gardenia jasminoides Ellis and Crocus sativus L, was examined in rats. In diet-induced hyperlipidemic rats, a 10-day treatment with crocin significantly reduced serum triglyceride, total cholesterol, low density lipoprotein (LDL) cholesterol and very low density lipoprotein (VLDL) cholesterol level in the daily dose range of 25 to 100 mg/kg. Results of the modified fat-loading method indicated that crocin inhibited the absorption of fat and cholesterol and this inhibition is closely related to the hydrolysis of fat. In addition, the modified fat-balance method demonstrated that crocin increased the fecal excretion of fat and cholesterol in rats, but had no influence on the elimination of bile acids. The results of the in situ loop method and enzyme assay indicated that crocin could not directly block the absorption of cholesterol from rat jejunum but could selectively inhibit the activity of pancreatic lipase as a competitive inhibitor. These findings suggest that crocin yielded its hypolipidemic effect by inhibiting pancreatic lipase, leading to the malabsorption of fat and cholesterol. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:116 / 122
页数:7
相关论文
共 34 条
[1]  
AKASAKA K, 1987, ANAL LETT, V20, P1581
[2]   Orally administered crocetin and crocins are absorbed into blood plasma as crocetin and its glucuronide conjugates in mice [J].
Asai, A ;
Nakano, T ;
Takahashi, M ;
Nagao, A .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2005, 53 (18) :7302-7306
[3]  
BARBARE JC, 1999, DRUGS TODAY BARC, V35, P139
[4]  
BELFRAGE P, 1969, J LIPID RES, V10, P341
[5]  
BOLLMAN JL, 1948, J LAB CLIN MED, V33, P1349
[6]  
CZUBAYKO F, 1991, J LIPID RES, V32, P1861
[7]  
[杜鹏 Du Peng], 2004, [中国新药杂志, Chinese Journal New Drugs], V13, P801
[8]   COLESTIPOL AND CHOLESTYRAMINE RESIN - COMPARATIVE EFFECTS IN FAMILIAL TYPE II HYPERLIPOPROTEINEMIA [J].
GLUECK, CJ ;
FORD, S ;
STEINER, P ;
SCHEEL, D .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1972, 222 (06) :676-&
[9]   Orlistat for the long-term treatment of obesity [J].
Harp, JB .
DRUGS OF TODAY, 1999, 35 (02) :139-145
[10]   Identification of a receptor mediating absorption of dietary cholesterol in the intestine [J].
Hauser, H ;
Dyer, JH ;
Nandy, A ;
Vega, MA ;
Werder, M ;
Bieliauskaite, E ;
Weber, FE ;
Compassi, S ;
Gemperli, A ;
Boffelli, D ;
Wehrli, E ;
Schulthess, G ;
Phillips, MC .
BIOCHEMISTRY, 1998, 37 (51) :17843-17850